RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 148 filers reported holding RELAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,223,216 | -53.3% | 264,354 | -30.2% | 0.00% | – |
| Q2 2023 | $4,757,175 | -53.9% | 378,756 | -39.5% | 0.00% | -100.0% |
| Q1 2023 | $10,308,622 | +94.6% | 625,903 | +76.6% | 0.00% | 0.0% |
| Q4 2022 | $5,296,066 | +55.7% | 354,489 | +133.2% | 0.00% | – |
| Q3 2022 | $3,401,000 | +67.4% | 152,026 | +25.3% | 0.00% | – |
| Q2 2022 | $2,032,000 | -19.9% | 121,361 | +43.1% | 0.00% | – |
| Q1 2022 | $2,538,000 | -46.0% | 84,819 | -44.6% | 0.00% | – |
| Q4 2021 | $4,703,000 | +310.7% | 153,144 | +321.8% | 0.00% | – |
| Q3 2021 | $1,145,000 | -49.0% | 36,310 | -40.8% | 0.00% | – |
| Q2 2021 | $2,243,000 | +65.9% | 61,296 | +56.6% | 0.00% | – |
| Q1 2021 | $1,352,000 | +286.3% | 39,131 | +363.7% | 0.00% | – |
| Q4 2020 | $350,000 | +560.4% | 8,439 | +583.3% | 0.00% | – |
| Q3 2020 | $53,000 | – | 1,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |